Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Julphar
Express Scripts
AstraZeneca
McKesson
Accenture
Medtronic
Cipla
McKinsey

Generated: May 26, 2018

DrugPatentWatch Database Preview

Tentative Approvals for: Akorn Inc

« Back to Dashboard

Akorn Inc Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Akorn Inc moxifloxacin 202916 0.5% SOLUTION; OPHTHALMIC
Akorn Inc timolol maleate 204912 0.5% SOLUTION;OPHTHALMIC
Akorn Inc palonosetron hydrochloride 204731 0.25MG(BASE)/5ML INJECTABLE;INJECTION
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Medtronic
Dow
Express Scripts
Covington
Accenture
Merck
Moodys
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.